CSL Limited – OTC:CSLLY
CSL Limited stock price today
$73.17
-14.70
-16.74%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
CSL Limited stock price monthly change
-16.07%
month
CSL Limited stock price quarterly change
-16.07%
quarter
CSL Limited stock price yearly change
-10.26%
year
CSL Limited key metrics
Market Cap | 101.95B |
Enterprise value | 95.63B |
P/E | 15.53 |
EV/Sales | 6.32 |
EV/EBITDA | 19.45 |
Price/Sales | 5.62 |
Price/Book | 2.44 |
PEG ratio | 0.43 |
EPS | 2.71 |
Revenue | 18.12B |
EBITDA | 3.72B |
Income | 1.85B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 18.08% |
Oper. margin | 25.31% |
Gross margin | 48.72% |
EBIT margin | 25.31% |
EBITDA margin | 20.57% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCSL Limited stock price history
CSL Limited stock forecast
CSL Limited financial statements
| Mar 2022 | 3.02B | 330.53M | 10.94% |
|---|---|---|---|
| Jun 2022 | 4.52B | 498.82M | 11.03% |
| Mar 2023 | 4.58B | 426.90M | 9.32% |
| Jun 2023 | 5.99B | 601.20M | 10.03% |
1.50%
Yield TTM
| Payout ratio | 44.66% |
|---|
| 2020 | 0.68% |
|---|---|
| 2021 | 0.74% |
| 2022 | 1.2% |
| 2023 | 1.22% |
| 2024 | 1.26% |
| Sep 2022 | 55422322600 | 27.46B | 49.56% |
|---|---|---|---|
| Dec 2022 | 35447600000 | 17.56B | 49.56% |
| Mar 2023 | 54198817200 | 27.53B | 50.8% |
| Jun 2023 | 36234000000 | 18.40B | 50.8% |
| Mar 2022 | 601.05M | -541.3M | 2.00B |
|---|---|---|---|
| Jun 2022 | 1.22B | -1.09B | 4.07B |
| Mar 2023 | 810.25M | -359.3M | -414.85M |
| Jun 2023 | 1.60B | -667.66M | -831.66M |
CSL Limited alternative data
| Aug 2023 | 30,000 |
|---|---|
| Sep 2023 | 32,065 |
| Oct 2023 | 32,065 |
| Nov 2023 | 32,065 |
| Dec 2023 | 32,065 |
| Jan 2024 | 32,065 |
| Feb 2024 | 32,065 |
| Mar 2024 | 32,065 |
| Apr 2024 | 32,065 |
| May 2024 | 32,065 |
| Jun 2024 | 32,065 |
| Jul 2024 | 32,065 |
CSL Limited other data
| Quarter | Transcript |
|---|---|
| Q2 2024 13 Feb 2024 | Q2 2024 Earnings Call Transcript |
| Q4 2023 15 Aug 2023 | Q4 2023 Earnings Call Transcript |
| Q2 2023 14 Feb 2023 | Q2 2023 Earnings Call Transcript |
| Q4 2022 17 Aug 2022 | Q4 2022 Earnings Call Transcript |
Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)
Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth
Arcturus: H1 2024 Rare Disease Drug Data On Deck
CSL Limited: Positive Capital Return And Earnings Growth Expectations
Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment
CSL: Watch Out For Positive Surprises
Starpharma: Patience Needed, But A Lot To Like
CSL Limited: Fiscal 2024 Outlook In The Spotlight
Market Is Still Not Pricing In The FDA And EU EMA Approvals For uniQure
-
What's the price of CSL Limited stock today?
One share of CSL Limited stock can currently be purchased for approximately $73.17.
-
When is CSL Limited's next earnings date?
Unfortunately, CSL Limited's (CSLLY) next earnings date is currently unknown.
-
Does CSL Limited pay dividends?
Yes, CSL Limited pays dividends and its trailing 12-month yield is 1.5% with 45% payout ratio. The last CSL Limited stock dividend of undefined was paid on 5 Sep 2025.
-
How much money does CSL Limited make?
CSL Limited has a market capitalization of 101.95B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 24.99% to 14.69B US dollars.
-
What is CSL Limited's stock symbol?
CSL Limited is traded on the OTC under the ticker symbol "CSLLY".
-
What is CSL Limited's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of CSL Limited?
Shares of CSL Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does CSL Limited have?
As Jul 2024, CSL Limited employs 32,065 workers.
-
When CSL Limited went public?
CSL Limited is publicly traded company for more then 6 years since IPO on 21 Nov 2018.
-
What is CSL Limited's official website?
The official website for CSL Limited is csl.com.au.
-
Where are CSL Limited's headquarters?
CSL Limited is headquartered at 45 Poplar Road, Parkville, VIC.
-
How can i contact CSL Limited?
CSL Limited's mailing address is 45 Poplar Road, Parkville, VIC and company can be reached via phone at +61 3 9389 1911.
CSL Limited company profile:
CSL Limited
csl.com.auExchange:
OTC
Full time employees:
30,000
Industry:
Biotechnology
Sector:
Healthcare
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
45 Poplar Road
Parkville, VIC 3052
Parkville, VIC 3052
CIK: 0001274152
ISIN: US12637N2045
CUSIP: 12637N204
